Abstract | OBJECTIVE: METHODS: The CD gene was used to construct the recombinant plasmid prostate-specific membrane antigen(promoter/enhancer)-CD (pPSMA(E/P)-CD). The specific regulatory function of the pPSMA(E/P) promoter was demonstrated by detection of enhanced green fluorescent protein (EGFP) expression in the LNCaP cell line. Survival of cells transfected with different plasmids and treated with 5-fluorocytosine (5-FC) was measured by microculture tetrazolium assay. Cell cycle changes were measured by flow cytometry. RESULTS: Target-specific expression of PSMA(E/P) was observed in the prostate cancer cell line. Cytotoxicity of 5-FC was greater against LNCaP cells transfected with pPSMA(E/P)-CD and UPRT and pPSMA(E/P)-CD than control groups. Percentages of cells in S phase were 37.5% (LNCaP) and 30.6% (5-FC treatment) in the un-transfected groups, whereas they were 23.9% and 12.4% in the double and single suicide gene groups, respectively. CONCLUSIONS: Our findings confirm the cytotoxic efficacy of the pPSMA(E/P)-CD + 5-FC and pPSMA(E/P)-CD and UPRT + 5-FC suicide gene systems. The CD and UPRT gene system quickly and directly converted 5-FC into 5-FU, and then into toxic metabolites. The CD and UPRT double suicide gene system was more effective in inducing tumor cell apoptosis with 5-FC than the single suicide gene system. Thus, this construct can specifically target prostate cancer cells and might have a role in gene therapy against prostate cancer.
|
Authors | Peng Zhang, Hao Zeng, Qiang Wei, Yiping Lu, Xiang Li, Jia Wang, Fujun Zhao, Hong Li |
Journal | International journal of urology : official journal of the Japanese Urological Association
(Int J Urol)
Vol. 15
Issue 5
Pg. 442-8
(May 2008)
ISSN: 1442-2042 [Electronic] Australia |
PMID | 18452463
(Publication Type: Journal Article)
|
Chemical References |
- Antigens, Surface
- Pentosyltransferases
- uracil phosphoribosyltransferase
- FOLH1 protein, human
- Glutamate Carboxypeptidase II
- Cytosine Deaminase
|
Topics |
- Antigens, Surface
(genetics)
- Cell Line, Tumor
- Cytosine Deaminase
(genetics)
- Enhancer Elements, Genetic
- Glutamate Carboxypeptidase II
(genetics)
- Humans
- Male
- Pentosyltransferases
(genetics)
- Promoter Regions, Genetic
- Prostatic Neoplasms
(therapy)
- Targeted Gene Repair
|